That Had To Hurt!
On September 11, GlaxoSmithKline (NYSE: GSK) agreed to a settlement with IRS which requires GSK to pay more than $3 billion in back taxes. Yes, billion. With a b. The IRS has been pursuing a claim with GSK since 2001 when it sent the company a bill for $8.6 billion for back taxes and interest. The tax…
